Stockreport

Compounder sues Lilly and Novo for suppressing GLP-1RA competition [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Strive Compounding Pharmacy said that the drugmakers, who dominate the glucagon-like peptide-1 receptor agonist (GLP-1RA) market, are engaging in a “coordinated effort [Read more]